Page last updated: 2024-11-05

triazolam and Tremor

triazolam has been researched along with Tremor in 2 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bechelli, LP1
Navas, F1
Pierangelo, SA1
Lamb, RJ1
Griffiths, RR1

Other Studies

2 other studies available for triazolam and Tremor

ArticleYear
Comparison of the reinforcing properties of zopiclone and triazolam in former alcoholics.
    International pharmacopsychiatry, 1982, Volume: 17 Suppl 2

    Topics: Adult; Alcoholism; Anti-Anxiety Agents; Azabicyclo Compounds; Capsules; Double-Blind Method; Electro

1982
Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons.
    European journal of pharmacology, 1985, Apr-02, Volume: 110, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Convulsants; Diazepam; Drug Tolerance; Flumazenil;

1985